About The Study: Researchers found in this study that among Medicare beneficiaries initiating opioid use disorder-related care during the COVID-19 pandemic, receipt of opioid use disorder-related telehealth services was associated with reduced risk for fatal drug overdose, as was receipt of medications for opioid use disorder from opioid treatment programs and receipt of buprenorphine in office-based settings.
Authors: Christopher M. Jones, Pharm.D., Dr.P.H., M.P.H., of the Centers for Disease Control and Prevention in Atlanta, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(10.1001/jamapsychiatry.2023.0310)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2023.0310?guestAccessKey=c1447a53-113b-46d3-976c-bada3638c308&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032923
JAMA Psychiatry